These observations expand our understanding of both PANX1 and β-catenin regulation and establish a novel cross talk between PANX1 and the Wnt signaling pathway that can potentially be target for new therapeutic interventions in patients with malignant melanoma. Here, PANX1 is linked to melanoma.